High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany: a prospective screening analysis of 28,809 patients
about
Chronic HCV infection: epidemiological and clinical relevanceInjecting drug use: A vector for the introduction of new hepatitis C virus genotypesEpidemiology of hepatitis C in Croatia in the European contextEmerging therapies for the treatment of hepatitis CAre the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in EuropeOutcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study.Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.The management of needlestick injuriesPrevalence of Hepatitis C infection in Qeshm Island in 2013-2014, Iran.Historical epidemiology of hepatitis C virus (HCV) in selected countries.Literature review of the distribution of hepatitis C virus genotypes across Europe.High seroprevalence of HCV in the Abruzzo Region, Italy: results on a large sample from opt-out pre-surgical screening.The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials.Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial.[Prevalence of blood-borne pathogens among 275 trauma patients : A prospective observational study].Liver transplantation in Germany.Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism.
P2860
Q21261812-F370EDAE-03A4-47F7-9465-168C5ED81D1BQ26781991-9077FC48-9D81-43AD-BA7C-B06740FE6123Q26795602-909C943D-E2E1-4A0A-B519-11EBA0C50EE3Q27003319-9F2BA950-375C-4F1F-AC8D-C34146DDEE57Q28069741-945E75AF-92CF-4859-BE1A-5EF901E893DFQ30376341-76419456-53CF-4D8A-9EFE-E9244536712AQ34137291-09BBA58A-0D8A-40F0-A615-52B19A328DF0Q36622163-CEC7A807-3A54-4F8C-9EBD-64F4F8F7B248Q37698052-CE3F1098-69A7-4CB1-88F8-1FE8E068FE57Q38203033-C8105F2C-2DA2-46AF-AD6F-C0E14E5CDB43Q38832756-BBE6CADC-1FCD-4373-9825-C015A7D13CE2Q38964724-4ED93022-F539-442F-B255-19CB3B75959CQ39213684-066B09EC-F1D5-4F50-AD9E-0DA00FC33511Q39591431-B33472E9-2FB1-4137-951B-CBD49A61C4B2Q40495015-B1C24A2D-B7B1-44CE-88A6-90BA1B854FD0Q40922424-E4655C9D-4A30-4F9F-A012-1FC38D2D29BFQ52139860-8FD9FB54-7990-4BAC-A208-760E4754B483Q54261265-9DC35D11-AF39-4969-867F-CFBE8548D882
P2860
High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany: a prospective screening analysis of 28,809 patients
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
High prevalence of anti-HCV an ...... ng analysis of 28,809 patients
@ast
High prevalence of anti-HCV an ...... ng analysis of 28,809 patients
@en
High prevalence of anti-HCV an ...... ng analysis of 28,809 patients
@nl
type
label
High prevalence of anti-HCV an ...... ng analysis of 28,809 patients
@ast
High prevalence of anti-HCV an ...... ng analysis of 28,809 patients
@en
High prevalence of anti-HCV an ...... ng analysis of 28,809 patients
@nl
prefLabel
High prevalence of anti-HCV an ...... ng analysis of 28,809 patients
@ast
High prevalence of anti-HCV an ...... ng analysis of 28,809 patients
@en
High prevalence of anti-HCV an ...... ng analysis of 28,809 patients
@nl
P2093
P2860
P3181
P1433
P1476
High prevalence of anti-HCV an ...... ng analysis of 28,809 patients
@en
P2093
Annemarie Berger
Beate Schlosser
Christian Müller
Christoph Sarrazin
Diana Domke
Felix Walcher
Gudrun Hintereder
Johannes Vermehren
Karin Hensel-Wiegel
Martin Möckel
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0041206
P407
P577
2012-01-01T00:00:00Z